AvenCell Raises $112 Million to Revolutionize Cancer Treatment with New Cell Therapy Technology

In a significant boost for cancer therapy innovation, AvenCell Therapeutics, Inc. has announced the successful closure of a $112 million Series B funding round. The financing, spearheaded by Novo Holdings, attracted new investors including F-Prime Capital, Eight Roads Ventures Japan, Piper Heartland Healthcare Capital, and NYBC Ventures, alongside existing backer Blackstone Life Sciences. This funding…

Read More

Axelera AI Secures $68 Million Series B Funding to Drive Next-Generation AI Solutions

Axelera AI, a pioneering force in AI hardware acceleration, has announced a landmark achievement with the closing of an oversubscribed $68 million Series B funding round. This significant investment, which brings Axelera AI’s total funding to $120 million, underscores its pivotal role in advancing AI technologies globally. Led by prominent investors including Invest-NL Deep Tech…

Read More

Cluby Secures €2.9 Million to Revolutionize Restaurant Connectivity Across Europe

In a bid to transform the way restaurants engage with their patrons, Finnish startup Cluby has announced a significant milestone in its journey: securing €2.9 million in Seed funding. This investment, led by Vendep Capital with participation from industry luminaries including Pekka Koskinen and Elias Aalto, marks a pivotal moment for Cluby as it accelerates…

Read More

Zen Educate Secures $37M Series B and Acquires Aquinas Education to Tackle Teacher Shortage

Zen Educate, an innovative online platform revolutionizing teacher recruitment, has successfully raised $37 million in a Series B funding round to address the pressing global teacher shortage. Founded in London in 2017 by Slava Kremerman and Oren Cohen, Zen Educate aims to streamline the hiring process by eliminating expensive third-party recruitment agencies, making it easier…

Read More

IceCure’s ProSense® Delivers 100% Success Rate in Breakthrough Cryoablation Study, Paving the Way for Non-Surgical Breast Cancer Treatment

IceCure Medical Ltd has announced a landmark achievement with its ProSense® cryoablation system, as detailed in a recent study published in the British Journal of Radiology. The study, conducted at Hospital Lucus Augusti in Lugo, Spain, demonstrates a 100% complete ablation rate for luminal A and B breast cancer tumors ≤ 25mm after a median…

Read More

Motion Secures $30 Million in Series B Funding to Empower Creative Strategists

Motion, the innovative creative analytics and research platform, has successfully raised $30 million in Series B funding, led by Inovia Capital with contributions from Threshold Ventures and existing investors including Headline, Abstract Ventures, and Sugar Capital. This latest funding round brings Motion’s total capital raised to $42 million, setting the stage for an accelerated product…

Read More

Cartken Secures $22.5M Funding to Pioneer Autonomous Navigation Technology

Cartken, a trailblazing robotics navigation software startup founded in Germany, has announced a significant funding milestone, raising $22.5 million to propel its advancements in autonomous navigation. The latest financing round, including a substantial $10 million injection, underscores Cartken’s commitment to revolutionizing industrial automation and last-mile delivery solutions. Cartken’s cutting-edge technology merges AI and computer vision…

Read More
Sirona Technologies Team

Sirona Technologies Secures €6M to Advance Direct Air Capture Technology

In a significant stride towards combating climate change, Sirona Technologies has successfully raised €6 million in a Seed round to propel its innovative Direct Air Capture (DAC) technology. This funding, co-led by LocalGlobe and XAnge, underscores growing investor confidence in Sirona’s mission to revolutionize carbon removal from the atmosphere. Founded in 2023 and headquartered in…

Read More

RareCyte Secures $20M to Expand Orion™ Spatial Biology Platform and Precision Biology Services

RareCyte, Inc., a pioneering Life Sciences company renowned for its Precision Biology platforms, has announced the successful completion of a $20 million financing round aimed at bolstering its Orion™ Spatial Biology platform. This funding, sourced from a blend of new and existing investors, including Forest Road, Arboretum Ventures, and F-Prime Capital, underscores RareCyte’s commitment to…

Read More